Hironic Co., Ltd. (KOSDAQ:149980)

Elevation Oncology Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	74,737	100,569	126,608	105,117	100,519	64,253
Market Cap Growth	-37.78%	-20.57%	20.44%	4.57%	56.44%	-8.73%
Enterprise Value	58,037	80,436	109,379	84,070	83,575	53,622
Last Close Price	5090.00	6300.00	7775.00	6454.55	6174.24	3907.97
PE Ratio	-	-	15.39	28.85	14.85	20.22
PS Ratio	2.39	3.18	3.75	3.81	4.62	4.95
PB Ratio	1.12	1.44	1.75	1.76	1.80	1.54
P/TBV Ratio	1.12	1.45	1.76	1.77	1.81	1.56
P/FCF Ratio	21.96	29.73	-	26.61	-	17.05
P/OCF Ratio	15.40	19.18	-	23.37	235.67	15.64
EV/Sales Ratio	1.86	2.54	3.24	3.05	3.84	4.13
EV/EBITDA Ratio	-	-	17.01	17.88	15.07	23.82
EV/EBIT Ratio	-	-	20.75	23.48	18.05	43.40
EV/FCF Ratio	17.05	23.78	-	21.28	-	14.23
Debt / Equity Ratio	-	-	0	0.05	0.05	0.00
Debt / EBITDA Ratio	-	-	0.00	0.60	0.48	0.02
Debt / FCF Ratio	-	-	-	0.71	-	0.01
Asset Turnover	0.39	0.40	0.45	0.41	0.40	0.28
Inventory Turnover	0.95	1.06	0.92	0.94	0.77	0.56
Quick Ratio	2.09	3.78	6.94	5.92	6.84	9.13
Current Ratio	6.83	7.20	11.95	9.54	12.16	15.26
Return on Equity (ROE)	-7.62%	-7.71%	12.47%	6.29%	13.86%	7.36%
Return on Assets (ROA)	-3.04%	-3.76%	4.43%	3.36%	5.34%	1.69%
Return on Capital (ROIC)	-3.41%	-4.20%	4.88%	3.69%	5.77%	1.82%
Return on Capital Employed (ROCE)	-	-	7.00%	5.50%	7.60%	2.90%
Earnings Yield	-7.14%	-5.42%	6.50%	3.47%	6.74%	4.95%
FCF Yield	4.55%	3.36%	-1.59%	3.76%	-1.14%	5.86%
Payout Ratio	-	-	-	-	8.92%	22.15%
Buyback Yield / Dilution	3.27%	0.14%	14.37%	-20.01%	1.26%	1.40%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.